The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
BRH- red this morning :)
She can, however, raise awareness of it within political circles - she can specifically ask the DHSC about it, the minister or even the PM if she wants.
She can do so in Parliament or behind the scenes.
Locally she has contacts at senior levels in Health, Social Care and Business.
Equally, should could do absolutely nothing or try hard and be ignored.
...the first progress update RNS now it seems these lot have cleared off?
I'll take a punt at this afternoon or tomorrow AM.
We're all smiling now after such an arduous week.
Onwards and upwards.
Well done to those who held or were able to top-up during these dark days!
WFH- HAS NOT SOLD HIS SHARES.
Sods law that now I've posted they've started taking higher numbers...
Just doing a dummy trade and couldn't sell. Playing around can only get a price up to 12,500 shares to sell.
Not sure what to make of that but 12501+ is NT.
Let them try.
Who would be stupid enough to sell now?!
What's your problem?
Think its holding up quite nicely so far given the latest vaccine news. Looking positive for later this week.
This share is amazing to be in. Would love to be be back in profit with it though!
If it isn't one thing its another.
Again, this drop will be fully misguided. Lets hope lessons have been learnt and it doesn't go too far.
Desperate. Do one.
Couldn't agree more.
Now its just a case of waiting for the first real step up which is clearly imminent. Looks like its gonna be a fun time through to Christmas!
OK just a minor rant! Call it therapy :)
Was 50% up overall yesterday AM. Fully expected it to hold or move a few percent from where it was but not to spend the full day plunging then the same today.
Fundamentally this is sound in my opinion -
The masks are not just going to be useful for covid but the defacto standard in masks going forwards.
Whatever happens with the range of vaccines coming to market, the culture about mask wearing in the west has changed - and maybe it should given the risk of other novel viruses emerging but for simple infection control reducing the spread of colds, flu and other "minor" ailments.
Demand is quoted as >5m masks a month at present. This, in my view, is the tip of the iceberg - healthcare and social care providers are likely to want these, anything which requires people of different households to mix in enclosed environments (from airlines and cinemas to the gas man coming to your home, concerts and other occasions.
Providing these are protected (patented), well marketed and production is scaled up (directly or via licence) then this company should rocket in value.
I don't know how much of this is MM games, misinformed PI's panicking or other big investors without a clue but it needs to turn around PDQ.
Reckon once orders start being reported and production is in effect it should be fine - just hoping i have the nerve to see my money disappear in the meantime.
That said, we all know - "hold for gold" and "it isn't a loss until you sell". Both my mantra for this morning.
Too right. Its the market saying "how dare you be successful".
Ridiculous.
We knew but we didn't know how deep it was going to go.
I didn't want to be in a position where I could have sold on the way down and bought double or more shares at the bottom.
Sold and rebought on that drop. More or less negligible profit but now have a nice round amount of shares.
Anti MM posts are ten a penny. They're all over the place every day. Correlation is not causation.
Demand in excess of 5m per month eh... easy! :)
>I suppose Gareth has invested in himself; his investment at the current share price is worth around £11 million, and rising.
Interesting.. so we're surmising that contrary to my previous post (1356) that unless an inventor invests their own cold hard cash in the spin-off company, they have no right to a risk free profit if they've developed the product from a grant and/or as part of their salaried position?
Thanks for doing some digging Jarv.
It does appear in a general sense that this kind of development is a win-win for the creator.
They can create IP via a grant whilst being paid by their employer. If it goes somewhere they seem to have rights to make a profit from it, if not, they've lost nothing.
Don't get me wrong, I'm in here and happy with the product but the general principle doesn't seem right. That's a broad comment on how this appears to work in the academic sector rather than a specific point about this company/product.